2017-2025 World Oncology Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
- HEY3349335
- 102 Pages
- November 2019
- Healthcare
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Oncology Biosimilars , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Oncology Biosimilars market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
By End-User / Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Company
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd
1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 North America Market
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 Europe Market
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 Asia-Pacific Market
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 South America Market
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 Middle East & Africa Market
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Nanchang Sanyou Industrial Celltrion Inc.
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Pfizer Inc.
12.3 Biocon
12.4 BIOCAD
12.5 Apotex Inc.
12.6 Dr. Reddy's
12.7 Sandoz International GmbH
12.8 Intas Pharmaceuticals Ltd.
12.9 STADA Arzneimittel AG
12.10 Teva Pharmaceutical Industries Ltd
13 Price Overview
13.1 Price Segment
13.2 Price Trend
14 Research Conclusion
Table Global Oncology Biosimilars Market and Growth by Type
Table Global Oncology Biosimilars Market and Growth by End-Use / Application
Table Global Oncology Biosimilars Revenue (Million USD) by Vendors (2017-2019)
Table Global Oncology Biosimilars Revenue Share by Vendors (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Vendors (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Global Oncology Biosimilars Market Share by Type (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Type (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Type (2017-2019)
Table Global Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by End-Use / Application (2017-2019)
Table Global Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Global Oncology Biosimilars Market Share by Regions (2017-2019)
Table Global Oncology Biosimilars Market Volume (Volume) by Regions (2017-2019)
Table Global Oncology Biosimilars Market Volume Share by Regions (2017-2019)
Table North America Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table North America Oncology Biosimilars Market Share by Type (2017-2019)
Table North America Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table North America Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table North America Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table North America Oncology Biosimilars Market Share by Regions (2017-2019)
Table Europe Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Europe Oncology Biosimilars Market Share by Type (2017-2019)
Table Europe Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Europe Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Europe Oncology Biosimilars Market Share by Regions (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by Type (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Oncology Biosimilars Market Share by Regions (2017-2019)
Table South America Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table South America Oncology Biosimilars Market Share by Type (2017-2019)
Table South America Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table South America Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table South America Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Type (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Oncology Biosimilars Market Share by Regions (2017-2019)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Share Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market Volume Share Forecast by Regions (2020-2025)
Table Global Oncology Biosimilars Market (Million USD) Forecast by Type (2020-2025)
Table Global Oncology BiosimilarsMarket Share by Forecast Type (2020-2025)
Table Global Oncology Biosimilars Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Oncology Biosimilars Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Celltrion Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Biocon
Table Sales Revenue, Volume, Price, Cost and Margin of BIOCAD
Table Sales Revenue, Volume, Price, Cost and Margin of Apotex Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Dr. Reddy's
Table Sales Revenue, Volume, Price, Cost and Margin of Sandoz International GmbH
Table Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of STADA Arzneimittel AG
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
